1. Suven Pharmaceuticals
stock logo

100% Buy

Suven Pharmaceuticals Share Price

SUVENPHAR

₹1,334.95+₹14.35 (1.09%) TodayLast updated on 05 Nov, 2024 | 12:44 IST

Suven Pharmaceuticals Share Price Chart

Please wait...
  • About Suven Pharmaceuticals
  • Fundamentals
  • Events
  • More
  • News

About Suven Pharmaceuticals

Suven Pharmaceuticals Financials

arrow
Market cap
Market Cap Switch₹33,435 Crs
Open
₹1,326.00
Close
₹1,320.60
Circuit range
₹1,584.70 - ₹1,056.50
Day range
₹1,313.80 - ₹1,353.95
Year range
₹542.10 - ₹1,353.95
Volume
3,99,815
Avg. traded
₹1,334.64
Revenue (12m)
₹934 Crs
Suven PharmaceuticalsSuven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Manufacturing segment. Its geographical segments include India, the United States, Europe, and Rest of the world. In India, the Company sells bulk drugs and intermediates, fine chemicals & services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s subsidiaries are Suven Pharma Inc. and Casper Pharma Private Limited.

Suven Pharmaceuticals Key indicators

arrow
52 week high
₹1,353.95
52 week low
₹542.10
P/E ratio
138.89
P/B ratio
15.42
ROE
16.03%
ROCE
21.27%
Dividend yield
--
Debt/Equity ratio
0.02
EPS
11.97

Learn more

Investment checklist: (5/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Suven Pharmaceuticals Fundamentals

Suven Pharmaceuticals Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

45.37%

Net profit margin

29.74%

ROE

16.03%

ROA

13.73%

ROCE

21.27%

Learn more

Suven Pharmaceuticals Shareholder returns

arrow
1 day
-0.49%
1 week
+4.24%
1 month
+10.06%
3 months
+31.97%
1 year
+137.09%
3 years
+160.09%
5 years
+683.65%

Suven Pharmaceuticals Share Price history

arrow
DayOpenCloseChange %
Mon, Nov 4 2024
₹1,334.10
₹1,320.60
-0.49%
Fri, Nov 1 2024
₹1,309.00
₹1,327.15
+1.05%
Thu, Oct 31 2024
₹1,281.85
₹1,313.40
+2.79%
Wed, Oct 30 2024
₹1,279.50
₹1,277.75
-0.10%
Tue, Oct 29 2024
₹1,266.90
₹1,279.00
+0.96%
Mon, Oct 28 2024
₹1,262.40
₹1,266.90
+1.36%
Fri, Oct 25 2024
₹1,260.85
₹1,249.90
-1.10%
Thu, Oct 24 2024
₹1,250.00
₹1,263.85
+1.10%

Suven Pharmaceuticals Shareholding Pattern

arrow

Promoters (50.1%)

Mutual Funds (14.12%)

Retail and other (22.25%)

Foreign institutions-FII (10.7%)

Other domestic institutions (2.83%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹1/share

    Ex date 09 Sep 2022

    expand tab
  • Dividend • ₹5/share

    Ex date 09 Sep 2022

    expand tab
  • Dividend • ₹1/share

    Ex date 13 May 2022

    expand tab
  • Dividend • ₹1/share

    Ex date 13 May 2022

    expand tab
  • Dividend • ₹1/share

    Ex date 15 Feb 2022

    expand tab
  • Dividend • ₹2/share

    Ex date 15 Feb 2022

    expand tab

Learn more

FAQs on Suven Pharmaceuticals